From: Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
Signs of altered immune response | References |
---|---|
Presence of HLA-DR or LFA-1 (leucocyte function-associated antigen) positive reactive microglia around senile plaques | |
Increased hippocampal gene expression of MHC II in AD compared to high-pathology controls | [95] |
Elevated brain levels of IL-1β and S-100 | [3] |
Presence of activated elements of classical complement pathway (C1q, C3d, C4d) within dystrophic neurites, NFTs and/or Aβ plaques | |
Up-regulated mRNA levels of complement elements C1q and C9 in AD brain | [97] |
Strong IL-6 immunoreactivity around plaques and large cortical neurons | [38] |
Low levels of TNFa in brain areas with AD pathology | [39] |
Increased levels of TNFa in sera of severe stage AD patients | [98] |
Increased levels of intracellular neuronal IL10, IFNγ and IL12 in AD patients compared to age-matched controls | [99] |
Correlations between Mini Mental State Examination scores and in vivo imaging marker [11C](R)PK11195-PET of activated microglia in AD patients | [42] |